Herein, we substantiated that POGK gene expression correlated with the abundance of immune cells in the tumor microenvironment of HCC, suggesting it can be a potent therapeutic target for this patient population, emphasizing the need for more studies. The gene discussed is POGK; the disease is hepatocellular carcinoma.